Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017

This cross-sectional study analyzes data on aggregate utilization and aggregate spending by patients and by pharmacy benefit managers to pharmacies for every brand-name drug prescription dispensed to all fully insured patients and some self-insured patients with commercial insurance in Massachusetts...

Descripción completa

Detalles Bibliográficos
Autores principales: Aaron, Micah B., Sinaiko, Anna D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994951/
https://www.ncbi.nlm.nih.gov/pubmed/33764422
http://dx.doi.org/10.1001/jamanetworkopen.2021.3252
_version_ 1783669862946570240
author Aaron, Micah B.
Sinaiko, Anna D.
author_facet Aaron, Micah B.
Sinaiko, Anna D.
author_sort Aaron, Micah B.
collection PubMed
description This cross-sectional study analyzes data on aggregate utilization and aggregate spending by patients and by pharmacy benefit managers to pharmacies for every brand-name drug prescription dispensed to all fully insured patients and some self-insured patients with commercial insurance in Massachusetts from 2015 to 2017.
format Online
Article
Text
id pubmed-7994951
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-79949512021-04-12 Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017 Aaron, Micah B. Sinaiko, Anna D. JAMA Netw Open Research Letter This cross-sectional study analyzes data on aggregate utilization and aggregate spending by patients and by pharmacy benefit managers to pharmacies for every brand-name drug prescription dispensed to all fully insured patients and some self-insured patients with commercial insurance in Massachusetts from 2015 to 2017. American Medical Association 2021-03-25 /pmc/articles/PMC7994951/ /pubmed/33764422 http://dx.doi.org/10.1001/jamanetworkopen.2021.3252 Text en Copyright 2021 Aaron MB et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Aaron, Micah B.
Sinaiko, Anna D.
Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
title Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
title_full Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
title_fullStr Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
title_full_unstemmed Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
title_short Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
title_sort spending and out-of-pocket prices for brand-name drugs among commercially insured individuals in massachusetts, 2015-2017
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994951/
https://www.ncbi.nlm.nih.gov/pubmed/33764422
http://dx.doi.org/10.1001/jamanetworkopen.2021.3252
work_keys_str_mv AT aaronmicahb spendingandoutofpocketpricesforbrandnamedrugsamongcommerciallyinsuredindividualsinmassachusetts20152017
AT sinaikoannad spendingandoutofpocketpricesforbrandnamedrugsamongcommerciallyinsuredindividualsinmassachusetts20152017

Ejemplares similares